Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Veiligheid en immunogeniciteit van 1 versus 2 doses tetravalent denguevaccin
sep 2017 | Virale infecties